IceCure Medical Ltd financials at a glance

+ Portfolio

The revenue of IceCure Medical Ltd is reported as 0.00323 billion Dollars in the fiscal year 2023. The earnings were -0.32 Dollars per share in 2023, which was 30.43 higher than 2022. And about -0.00089 billion Dollars are reported as free cash flow in the financials of IceCure Medical Ltd 2023. No dividends were paid to the shareholders of the IceCure Medical Ltd stock NasdaqCM:ICCM in the financial year 2023.

$3.23M

Revenue

$-0.32

Earnings Per Share

40.26%

Gross Margin %

$-15.28M

Free Cash Flow

Revenue

3.23

Earnings Per Share

-0.32

Gross Margin %

40.26

Free Cash Flow

-15.28

Financials

Year	Year	TTM	2023	2022	2021
Rev.	Revenue	N/A	$3.23M	$3.09M	$4.14M
GM %	Gross Margin %	55.69%	40.26%	46.84%	53.04%
OM	Operating Margin	-,127.78%	0.00%	0.00%	-,234.99%
EPS	Earnings Per Share	$-0.12	$-0.32	$-0.46	$-0.35
Div.	Dividends	N/A	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0
Sha.	Shares	N/AM	45.73M	45.62M	35.78M
OCF	Operating Cash Flow	N/A	$0.00M	$-14.29M	$0.00M
FCF	Free Cash Flow	N/A	$-15.28M	$-15.18M	$0.00M
FCFS	Free Cash Flow Per Share	$-0.02	$-0.28	$-0.41	$-0.46

IceCure Medical Ltd financials at a glance

Financials

Discover